ASCO 2019 | Biggest obstacles in lung cancer therapy

Roy Herbst

Roy Herbst, MD, PhD, FACP, FASCO, of Yale University, New Haven, CT, tells us about the difficulties the heterogeneity of lung cancer causes in the treatment of the disease. This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

Share this video